Biogen (BIIB) Non-Current Debt (2009 - 2025)

Biogen's Non-Current Debt history runs 9 years deep, the most recent figure standing at $6.3 billion for Q4 2025.

• In Q4 2025, Non-Current Debt rose 38.26% year-over-year to $6.3 billion; the TTM figure through Dec 2025 stood at $6.3 billion (up 38.26% YoY), while the FY2025 annual figure was $6.3 billion, up 38.26% from the prior year.
• Non-Current Debt was $6.3 billion for Q4 2025 at Biogen, up from $4.5 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $6.8 billion in Q4 2023 to a low of $4.5 billion in Q4 2024.
• Historically, Non-Current Debt has averaged $6.0 billion across 4 years, with a median of $6.3 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt sank 33.01% in 2024, then surged 38.26% in 2025.
• A 4-year view of Non-Current Debt shows it stood at $6.3 billion in 2022, then grew by 8.08% to $6.8 billion in 2023, then tumbled by 33.01% to $4.5 billion in 2024, then soared by 38.26% to $6.3 billion in 2025.
• The last three Non-Current Debt figures came in at $6.3 billion (Q4 2025), $4.5 billion (Q4 2024), and $6.8 billion (Q4 2023), per Business Quant data.